EVM
COLL icon

Eaton Vance Management’s Collegium Pharmaceutical COLL Stock Holding History

Eaton Vance Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-91
Closed -$2K – 1974
2021
Q4 		$2K Buy
+91
New +$1.77K ﹤0.01% 2723
2021
Q3 		– Sell
-392
Closed -$9K – 2129
2021
Q2 		$9K Buy
392
+290
+284% +$6.7K ﹤0.01% 2553
2021
Q1 		$2K Buy
+102
New +$2.42K ﹤0.01% 2757

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Eaton Vance Management's COLL Position: Q1 2022 in Review

Eaton Vance Management sold out of Collegium Pharmaceutical (COLL) in Q1 2022, closing a stake of 91 shares — an estimated $2K sold.

Eaton Vance Management first reported a position in COLL in Q1 2021 and held it in 3 quarters. The position peaked at $9K in Q2 2021. 172 funds tracked by Wall St. Rank hold COLL as of Q1 2022.

  • Eaton Vance Management reported no remaining Collegium Pharmaceutical position as of Q1 2022 after selling out during the quarter.
  • Eaton Vance Management sold 91 Collegium Pharmaceutical shares in Q1 2022, an estimated $2K.
  • Eaton Vance Management first reported a position in Collegium Pharmaceutical in Q1 2021 and held it in 3 quarters.
  • Eaton Vance Management's Collegium Pharmaceutical position peaked at $9K in Q2 2021.
  • 172 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2022.

Based on Eaton Vance Management's 13F filing for Q1 2022, filed 16 May 2022.